China Artificial Organs Market Research Report 2023: Organ Type, Technology, Material Type, Region, Competition, Forecast & Opportunities to 2028
DUBLIN, Nov. 28, 2023 /PRNewswire/ — The “China Artificial Organs Market by Organ Type, Technology, Material Type, Region, Competition, Forecast & Opportunities, 2028” report has been added to ResearchAndMarkets.com’s offering. The China artificial organs market is exp
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG
NEW YORK, Nov. 28, 2023 /PRNewswire/ –Pomerantz LLP is investigating claims on behalf of investors of SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (NASDAQ: SEDG). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 88
McCormick Announces Increase in Quarterly Dividend
HUNT VALLEY, Md., Nov. 28, 2023 /PRNewswire/ — The Board of Directors of McCormick & Company, Incorporated (NYSE:MKC) today declared an increase in the quarterly dividend from $0.39 to $0.42 per share on its common stocks, payable January 8, 2024 to shareholders of record December 29, 2023
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Rockley Photonics Holdings Limited – RKLY; RKLY.W
NEW YORK, Nov. 28, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Rockley Photonics Holdings Limited (“Rockley” or the “Company”) (NASDAQ: RKLY; RKLY.W). Such investors are advised to contact Robert S. Willoughby at newaction@poml
SeatCash Inc. Announces the Beta Launch of FareX.ai: The Next Generation Airfare Prediction Tool
CHICAGO, Nov. 28, 2023 /PRNewswire/ — SeatCash Inc., a leader in travel technology innovation is excited to announce the launch of FareX.ai, its proprietary airfare prediction tool. FareX.ai is designed to empower both businesses managing air travel procurement and individual travelers by prov
Navigating the Evolving Market Dynamics of Bone Sarcoma: A Comprehensive Analysis of Osteosarcoma, Ewing Sarcoma, and Chondrosarcoma | DelveInsight
Each individual’s risk of being diagnosed with primary bone sarcoma and their chances of recovery following diagnosis are influenced by a range of unique factors. In 2023, it is anticipated that 4K individuals of all ages in the United States will be diagnosed with primary bone sarcoma, includ
Humanforce Announces Strategic Partnership with Pinpoint HRM: Delivering Exceptional Customer Experiences for Frontline Workforces
SYDNEY, Nov. 29, 2023 /PRNewswire/ — Humanforce, an Australian-borne global provider of human capital management (HCM) solutions, today announced a new strategic partnership with Pinpoint HRM, leading HR technology project experts in the A/NZ region. This strategic partnership brings together
ALIMENTATION COUCHE-TARD ANNOUNCES ITS RESULTS FOR ITS SECOND QUARTER OF FISCAL YEAR 2024
Net earnings were $819.2 million, or $0.85 per diluted share for the second quarter of fiscal 2024 compared with $810.4 million, or $0.79 per diluted share for the second quarter of fiscal 2023. Adjusted net earnings1 were approximately $792.0 million compared with $838.0 million for the second quar
Metastatic Non-small Cell Lung Cancer Market Forecast Analysis and with Focus on its Immune/Molecular Biomarker Types: PD-L1, EGFR, KRAS, ALK, BRAF, MET, ROS-1, HER2, RET fusion, and NTRK1/2/3 Gene fusion | DelveInsight
The metastatic non-small cell lung cancer market size is expected to witness a revolutionary change in the coming decade owing to the increase in incident cases of NSCLC, continuous uptake of approved therapies, expected entry of potential premium price emerging therapies, and increasing awareness o
TCL Giving Away $1M in 98″ TVs Following 99-Yard Touchdown During Inaugural NFL Black Friday Game
Leading Electronics Brand Awards Big Screen TVs to Sweepstakes Entrants in “Ultimate Gameday Upgrade” IRVINE, Calif., Nov. 28, 2023 /PRNewswire/ — TCL®’s $1,000,000 prize – the largest purse in its Ultimate Gameday Upgrade sweepstakes – was officially unlocked in the ina
